EXPLANATORY NOTE

On July 2, 2021 (the “Closing Date”), Foley Trasimene Acquisition Corp. (“FTAC”), a Delaware corporation n/k/a Alight Group, Inc., completed its previously announced business combination transaction (the “Alight Business Combination”) contemplated by the Amended and ~~25,875,000 shares~~Restated Business Combination Agreement (the “Business Combination Agreement”), dated as of ~~Class B common stock~~April 29, 2021, by and among FTAC, Tempo Holding Company, LLC, a Delaware limited liability company (“Tempo”), Alight, Inc., a Delaware corporation (“Alight”), Acrobat SPAC Merger Sub, Inc., a Delaware corporation (“FTAC Merger Sub”), Acrobat Merger Sub, LLC, a Delaware limited liability company (“Tempo Merger Sub”), Acrobat Blocker 1 Corp., Acrobat Blocker 2 Corp., Acrobat Blocker 3 Corp. and Acrobat Blocker 4 Corp., each of which is a Delaware corporation (the “Blocker Merger Subs”), Tempo Blocker I, LLC, a Delaware limited liability company (“Tempo Blocker 1”), Tempo Blocker II, LLC, a Delaware limited liability company (“Tempo Blocker 2”), Blackstone Tempo Feeder Fund VII, L.P., a Delaware limited partnership (“Tempo Blocker 3”), New Mountain Partners IV Special (AIV-E2), LP, a Delaware limited partnership (“Tempo Blocker 4” and, together with Tempo Blocker 1, Tempo Blocker 2, Tempo Blocker 3 and Tempo Blocker 4, the “Tempo Blockers”) and New Mountain Partners IV Special (AIV-E), LP, a Delaware limited partnership.

On the Closing Date, pursuant to the Business Combination Agreement, among other things, (i) FTAC Merger Sub merged with and into FTAC, with FTAC being the surviving corporation in the merger and becoming a subsidiary of Alight (the “FTAC Merger”) and being renamed Alight Group, Inc. (in such capacity, the “FTAC Surviving Corporation”), (ii) Tempo Merger Sub merged with and into Tempo, with Tempo being the surviving company in the merger (the “Tempo Merger”), becoming a subsidiary of Alight and being renamed Alight Holding Company, LLC (in such capacity, “Alight Holdings”) and (iii) each of the Blocker Merger Subs merged with and into the correspondingly numbered Tempo Blocker, with the applicable Tempo Blocker being the surviving entity in such mergers. As a result of the Business Combination, and by virtue of such series of mergers and related transactions, the combined company is now organized in an “Up-C” structure, in which substantially all of the assets and business of Alight are held by Alight Holdings, of which Alight is the managing member pursuant to the terms of the Second Amended and Restated Limited Liability Company Agreement of Alight Holdings (the “Alight Holdings Operating Agreement”) that went into effect upon the completion of the Alight Business Combination.

Unless stated otherwise, this report contains information about FTAC before the Alight Business Combination. This Report covers a period prior to the closing of the Alight Business Combination. As a result, references in this report to “we,” “us,” “our,” or the “Company” refer to the registrant ~~issued and outstanding.~~prior to the closing of the Business Combination, unless the context requires otherwise.

Except as otherwise expressly provided herein, the information in this Report does not reflect the consummation of the Alight Business Combination, which, as discussed above, occurred subsequent to the period covered hereunder.

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

Quarterly Report on Form 10-Q

TABLE OF CONTENTS

			Page
PART 1 – FINANCIAL INFORMATION			1

Item 1.	Unaudited Condensed Consolidated Financial Statements		1

	Condensed Consolidated Balance ~~Sheet~~Sheets as of ~~September~~June 30, 2021 (Unaudited) and December 31, 2020 ~~(unaudited)~~		1

	Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended ~~September~~June 30, 2021 and 2020, for the Six Months Ended June 30, 2021, and for the Period from March 26, 2020 (inception) ~~Through September~~to June 30, 2020 ~~(unaudited)~~		2

	Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three and Six Months Ended ~~September~~June 30, ~~2020~~2021 and for the Period from March 26, 2020 (inception) ~~Through September~~to June 30, 2020 ~~(unaudited)~~		3

	Unaudited Condensed ~~Statement~~Consolidated Statements of Cash Flows for ~~the~~Six Months Ended June 30, 2021 and for the Period from March 26, 2020 (inception) ~~Through September~~to June 30, 2020 ~~(unaudited)~~		4

	Notes to Unaudited Condensed Consolidated Financial Statements ~~(unaudited)~~		5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		15 20

Item 3.	Quantitative and Qualitative Disclosures about Market Risk		18 24

Item 4.	Control and Procedures		18 24

PART II – OTHER INFORMATION			26

Item 1.1A.	~~Legal Proceedings~~Risk Factors		19 26

~~Item 1A.~~	~~Risk Factors~~		19

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		19 26

Item 3.6.	~~Defaults Upon Senior Securities~~Exhibits		19 27

~~Item 4.~~SIGNATURES		~~Mine Safety Disclosures~~		19

~~Item 5.~~	~~Other Information~~		19

~~Item 6.~~	~~Exhibits~~		20

~~SIGNATURES~~			21 28

Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

CONDENSED CONSOLIDATED BALANCE ~~SHEET~~SHEETS

~~SEPTEMBER 30, 2020~~


	June 30,		December 31,
	2021		2020
	(Unaudited)		(Audited)
ASSETS
Current Assets
Cash	$	14,551	$	496,471
Prepaid expenses		137,915		225,747
Total Current Assets		152,466		722,218

Investments held in Trust Account		1,036,010,297		1,035,849,267
TOTAL ASSETS	$	1,036,162,763	$	1,036,571,485

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accrued expenses	$	8,901,247	$	2,980,284
Income taxes payable		11,060		147,695
Due to sponsor		1,138,058		—
Total Current Liabilities		10,050,365		3,127,979

Warrant liability		105,507,333		127,388,332
Forward purchase liability		15,000,822		54,277,110
Deferred underwriting fee payable		36,225,000		36,225,000
Total Liabilities		166,783,520		221,018,421

Commitments and Contingencies

Class A common stock subject to possible redemption, 86,437,924 and 81,055,306 shares at $10.00 per share as of June 30, 2021 and December 31, 2020, respectively		864,379,240		810,553,063

Stockholders’ Equity
Preferred Stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—		—
Class A common stock, $0.0001 par value; 400,000,000 shares authorized; 17,062,076 and 22,444,694 shares issued and outstanding (excluding 86,437,924 and 81,055,306 shares subject to possible redemption as of June 30, 2021 and December 31, 2020, respectively)		1,706		2,244
Class B common stock, $0.00001 par value; 40,000,000 shares authorized; 25,875,000 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively		2,588		2,588
Additional paid-in capital		65,602,179		119,427,819
Accumulated deficit		(60,606,470)		(114,432,650)
Total Stockholders’ Equity		5,000,003		5,000,001
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,036,162,763	$	1,036,571,485

~~(Unaudited)~~

ASSETS
Current assets
Cash $ 579,370
Prepaid expenses 284,517
Total Current Assets 863,887

Cash and marketable securities held in Trust Account 1,035,519,281
Total Assets $ 1,036,383,168

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued expenses $ 121,016
Accrued offering costs 20,000
Income taxes payable 88,049
Total Current Liabilities 229,065

Deferred underwriting fee payable 36,225,000
Total Liabilities 36,454,065

Commitments and Contingencies

Class A common stock subject to possible redemption, 99,492,910 shares at $10.00 per share 994,929,100

Stockholders’ Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding —
Class A common stock, $0.0001 par value; 400,000,000 shares authorized; 4,007,090 issued and outstanding (excluding 99,492,910 shares subject to possible redemption) 401
Class B common stock, $0.0001 par value; 40,000,000 shares authorized; 25,875,000 shares issued and outstanding 2,588
Additional paid-in capital 4,842,957
Retained earnings 154,057
Total Stockholders’ Equity 5,000,003
Total Liabilities and Stockholders’ Equity $ 1,036,383,168

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months
Ended
September 30, For the Period
from March
26, 2020
(Inception)
Through
September 30,
2020 2020
Formation and general and administrative expenses $ 166,771 $ 277,175
Loss from operations (166,771 ) (277,175 )

Other income:
Interest earned on marketable securities held in Trust Account 394,825 519,281

Income before provision for income taxes 228,054 242,106
Provision for income taxes (72,413 ) (88,049 )
Net income $ 155,641 $ 154,057

Weighted average shares outstanding of Class A redeemable common stock 103,500,000 103,500,000
Basic and diluted income per share, Class A $ 0.00 $ 0.00

Weighted average shares outstanding of Class B non-redeemable common stock 25,875,000 25,875,000
Basic and diluted net loss per share, Class B $ (0.00 ) $ (0.01 )


							For the Period
							from March 26,
	Three Months				Six Months		2020 (Inception)
	Ended				Ended		through
	June 30,				June 30,		June 30,
	2021		2020		2021		2020

Formation and general and administrative expenses	$	4,175,988	$	109,445	$	7,433,772	$	110,404
Loss from operations		(4,175,988)		(109,445)		(7,433,772)		(110,404)

Other income (loss):
Interest earned on marketable securities held in Trust Account		24,979		124,456		161,030		124,456
Change in fair value of forward purchase liability		4,970,490		(18,909,921)		39,276,288		(18,909,921)
Change in fair value of warrant liability		(25,034,667)		(12,105,667)		21,880,999		(12,105,666)
Total other income (loss), net		(20,039,198)		(30,891,132)		61,318,317		(30,891,131)

Income (loss) before provision for income taxes		(24,215,186)		(31,000,577)		53,884,545		(31,001,535)
Provision for income taxes		(40,294)		(15,636)		(58,365)		(15,636)
Net income (loss)	$	(24,255,480)	$	(31,016,213)	$	53,826,180	$	(31,017,171)

Weighted average shares outstanding, Class A redeemable common stock		103,500,000		103,500,000		103,500,000		103,500,000

Basic and diluted net income per share, Class A	$	0.00	$	0.00	$	0.00	$	0.00

Weighted average shares outstanding, Class B non-redeemable common stock		25,875,000		25,875,000		25,875,000		25,875,000

Basic and diluted net income (loss) per share, Class B	$	(0.94)	$	(1.20)	$	2.08	$	(1.20)

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

CONDENSED ~~STATEMENT~~CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

FOR THE THREE MONTHS AND SIX MONTHS ENDED ~~SEPTEMBER~~JUNE 30, ~~2020 AND~~2021


	Class A			Class B			Additional				Total
	Common Stock			Common Stock			Paid-in		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Capital		Deficit		Equity (Deficit)
Balance - January 1, 2021	22,444,694	$	2,244	25,875,000	$	2,588	$	119,427,819	$	(114,432,650)	$	5,000,001

Change in value of common stock subject to possible redemption	(7,808,166)		(780)	—		—		(78,080,878)		—		(78,081,658)

Net income	—		—	—		—		—		78,081,660		78,081,660

Balance – March 31, 2021(unaudited)	14,636,528	$	1,464	25,875,000	$	2,588	$	41,346,941	$	(36,350,990)	$	5,000,003

Change in value of common stock subject to possible redemption	2,425,548		242	—		—		24,255,238		—		24,255,480

Net loss	—		—	—		—		—		(24,255,480)		(24,255,480)

Balance - June 30, 2021 (unaudited)	17,062,076	$	1,706	25,875,000	$	2,588	$	65,602,179	$	(60,606,470)	$	5,000,003

FOR THE PERIOD FROM MARCH 26, 2020 (INCEPTION) THROUGH ~~SEPTEMBER~~JUNE 30, 2020

~~(Unaudited)~~


	Class A			Class B			Additional				Total
	Common Stock			Common Stock			Paid-in		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Capital		Deficit		Equity
Balance - March 26, 2020 (inception)	0	$	0	0	$	0	$	0	$	0	$	0

Net loss	—		—	—		—		—		(959)		(959)

Balance – March 31, 2020 (unaudited)	—	$	—	—	$	—	$	—	$	(959)	$	(959)

Issuance of class B common stock to Sponsors	—		—	25,875,000		2,588		22,412		—		25,000

Sale of 103,500,000 Units, net of underwriting discounts and offering expenses	103,500,000		10,350	—		—		977,039,696		—		977,050,046

Sale of 15,133,133 Private Placement Warrants	—		—	—		—		22,700,000		—		22,700,000

Common stock subject to redemption	(89,396,854)		(8,940)	—		—		(893,959,600)		—		(893,968,540)

Initial classification of warrant liability	—		—	—		—		(69,789,333)		—		(69,789,333)

Net loss	—		—	—		—		—		(31,016,212)		(31,016,212)

Balance – June 30, 2020 (unaudited)	14,103,146	$	1,410	25,875,000	$	2,588	$	36,013,175	$	(31,017,171)	$	5,000,002

Class A Class B Additional (Accumulated
Deficit)/ Total
Common Stock Common Stock Paid-in Retained Stockholders’
Shares Amount Shares Amount Capital Earnings Equity
Balance – March 26, 2020 (inception) — $ — — $ — $ — $ — $ —

Net loss — — — — — (959 ) (959 )

Balance – March 31, 2020 — — — — — (959 ) (959 )

Issuance of Class B common stock to Sponsors — — 25,875,000 2,588 22,412 — 25,000

Sale of 103,500,000 Units, net of underwriting discounts 103,500,000 10,350 — — 977,039,696 — 977,050,046

Sale of 15,133,333 Private Placement Warrants — — — — 22,700,000 — 22,700,000

Common stock subject to possible redemption (99,477,346 ) (9,948 ) — — (994,763,512 ) — (994,773,460 )

Net loss — — — — — (625 ) (625 )

Balance – June 30, 2020 4,022,654 402 25,875,000 2,588 4,998,596 (1,584 ) 5,000,002

Change in value of common stock subject to possible redemption (15,564 ) (1 ) — — (155,639 ) — (155,640 )

Net income — — — — — 155,641 155,641

Balance – September 30, 2020 4,007,090 $ 401 25,875,000 $ 2,588 $ 4,842,957 $ 154,057 $ 5,000,003

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Table of Contents

ALIGHT, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

CONDENSED ~~STATEMENT~~CONSOLIDATED STATEMENTS OF CASH FLOWS

~~FOR THE PERIOD FROM MARCH 26, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020~~(Unaudited)

~~(Unaudited)~~


			For the
			Period
			from March
			26, 2020
	Six Months		(Inception)
	Ended		Through
	June 30,		June 30,
	2021		2020

Cash Flows from Operating Activities:
Net income (loss)	$	53,826,180	$	(31,017,171)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of forward purchase liability		(39,276,288)		18,909,921
Change in fair value of warrant liability		(21,880,999)		12,105,666
Interest earned on marketable securities held in Trust Account		(161,030)		(124,456)
Changes in operating assets and liabilities:
Prepaid expenses		87,832		(313,467)
Accrued expenses		5,920,962		89,014
Income taxes payable		(136,635)		15,636
Due to sponsor		1,138,058		—
Net cash used in operating activities		(481,920)		(334,857)

Cash Flows from Investing Activities:
Investment of cash into Trust Account		—		(1,035,000,000)
Net cash used in investing activities		—		(1,035,000,000)

Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor		—		25,000
Proceeds from sale of Units, net of underwriting discounts paid		—		1,014,300,000
Proceeds from sale of Private Placement Warrants		—		22,700,000
Proceeds from promissory note - related party		—		250,000
Repayment of promissory note - related party		—		(250,000)
Payment of offering cost		—		(404,954)
Net cash provided by financing activities		—		1,036,620,046

Net Change in Cash		(481,920)		1,285,189
Cash – Beginning		496,471		0
Cash - End	$	14,551	$	1,285,189

Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Change in value of Class A common stock subject to possible redemption	$	(53,826,178)	$	(31,010,447)
Initial classification of Class A common stock subject to possible redemption	$	—	$	924,978,987
Offering costs included in accrued offering costs	$	—	$	620,000
Deferred underwriting fee payable	$	—	$	36,225,000

Cash Flows from Operating Activities:
Net income $ 154,057
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account (519,281 )
Changes in operating assets and liabilities:
Prepaid expenses (284,517 )
Accounts payable and accrued expenses 121,016
Income taxes payable 88,049
Net cash used in operating activities (440,676 )

Cash Flows from Investing Activities:
Investment of cash into Trust Account (1,035,000,000 )
Net cash used in investing activities (1,035,000,000 )

Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor 25,000
Proceeds from sale of Units, net of underwriting discounts paid 1,014,300,000
Proceeds from sale of Private Placement Warrants 22,700,000
Proceeds from promissory note - related party 250,000
Repayment of promissory note - related party (250,000 )
Payment of offering costs (1,004,954 )
Net cash provided by financing activities 1,036,620,046

Net Change in Cash 579,370
Cash – Beginning of period —
Cash – End of period $ 579,370

Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Offering costs included in accrued offering costs $ 20,000
Initial classification of Class A common stock subject to possible redemption $ 994,768,320
Change in value of Class A common stock subject to possible redemption $ 160,780
Deferred underwriting fee payable $ 36,225,000

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.
)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
~~SEPTEMBER~~

JUNE 30, ~~2020~~
2021

(Unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Alight Group, Inc. (f/k/a Foley Trasimene Acquisition Corp.) (the “Company”) ~~is a blank check company~~was incorporated in Delaware on March 26, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).

~~Although the Company is not limited to a particular industry or geographic region for purposes of consummating a~~Alight Business Combination

On July 2, 2021 (the “Closing Date”), FTAC completed the ~~Company intends to focus on identifying a prospective target business in financial technology or business process outsourcing, which acts as an essential utility to industries that are core~~Alight Business Combination contemplated by the Business Combination Agreement. On the Closing Date, pursuant to the ~~economy. The~~Business Combination Agreement, among other things, (i) FTAC Merger Sub merged with and into FTAC, with FTAC being the surviving corporation in the merger and becoming a subsidiary of Alight (the “FTAC Merger”) and being renamed Alight Group, Inc. (in such capacity, the “FTAC Surviving Corporation”), (ii) Tempo Merger Sub merged with and into Tempo, with Tempo being the surviving company in the merger (the “Tempo Merger”), becoming a subsidiary of Alight and being renamed Alight Holding Company, LLC (in such capacity, “Alight Holdings”) and (iii) each of the Blocker Merger Subs merged with and into the correspondingly numbered Tempo Blocker, with the applicable Tempo Blocker being the surviving entity in such mergers. As a result of the Alight Business Combination, and by virtue of such series of mergers and related transactions, the combined company is now organized in an ~~early stage and emerging growth company and, as such, the Company is subject to~~“Up-C” structure, in which substantially all of the ~~risks associated~~assets and business of Alight are held by Alight Holdings, of which Alight is the managing member pursuant to the terms of the Alight Holdings Operating Agreement that went into effect upon the completion of the Alight Business Combination.

Capitalized terms not otherwise defined herein have the meaning set forth in FTAC’s definitive proxy statement and Alight’s final prospectus filed with ~~early stage~~the Securities and ~~emerging growth companies.~~Exchange Commission (the “Commission” or the “SEC”) in connection with the Business Combination on June 4, 2021 (the “Proxy Statement/Prospectus”).

Alight Capital Structure

As a result of ~~September 30, 2020,~~the Business Combination and pursuant to the Amended and Restated Certificate of Incorporation of the Company ~~had~~(the “Alight Charter”), Alight’s capital stock is now comprised of: (i) Class A common stock, par value $0.0001 per share (the “Alight Class A common stock”), which is traded on the New York Stock Exchange (the “NYSE”), (ii) Class B-1 common stock, par value $0.0001 per share (the “Alight Class B-1 common stock”), (iii) Class B-2 common stock, par value $0.0001 per share (the “Alight Class B-2 common stock”), (iv) Class B-3 common stock, par value $0.0001 per share, 0 shares of which are issued or outstanding, (v) Class V common stock, par value $0.0001 per share (the “Alight Class V Common Stock”), which are issued to holders of Class A Units of Alight Holdings (“Class A Units”) and provide voting rights in Alight and (vi) and preferred stock, which may be issued in from time to time by the board of directors of Alight (the “Alight Board”). The rights, powers, preferences and privileges of Alight’s capital stock are described in more detail in the Proxy Statement/Prospectus under the sections titled “Description of the Company’s Securities” and “Comparison of Stockholders’ Rights”.

Consideration

Pursuant to the terms of the Business Combination Agreement, at the effective time of the FTAC Merger (the “FTAC Effective Time”), the 119,298,699 shares of FTAC’s Class A common stock, par value $0.0001 per share, issued and outstanding (after giving effect to redemptions and the closing of the transactions contemplated by FTAC’s forward purchase agreements) and 23,287,500 shares of FTAC’s Class B common stock, par value $0.0001 per share, issued and outstanding (after giving effect to certain forfeitures thereof) were automatically converted into shares of Alight Class A common stock on a 1-for-one basis (or an aggregate of 142,586,199 shares of Alight Class A common stock). In addition, at the FTAC Effective Time, each FTAC warrant that was outstanding immediately prior to the FTAC Effective Time, each of which entitled the holder thereof to purchase 1 share of FTAC Class A Common Stock at a price of $11.50 per share (each, an “FTAC Warrant”) was, pursuant to the Business Combination Agreement and in accordance with the Warrant Agreement and the Warrant Assumption Agreement (each as defined below), automatically and irrevocably modified and exchanged for a warrant to purchase the same number of share(s) of Alight Class A common stock on the same terms and otherwise pursuant to the Warrant Agreement.

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

Alight was appointed and admitted as the managing member of Alight Holdings upon the effective time of the Tempo Merger (the “Tempo Effective Time”). Alight, as the managing member of Alight Holdings, has the sole authority to manage Alight Holdings in accordance with the Alight Holdings Operating Agreement and applicable law. No other member of Alight Holdings has the right to participate in or have any control over the business of Alight Holdings, and except for certain limited consent rights set forth in the Alight Holdings Operating Agreement, no member other than Alight (in its capacity as the managing member) has any right to vote on any matter involving Alight Holdings. The managing member solely manages the business, property and affairs of Alight Holdings, and the managing member cannot be removed or replaced except by the incumbent managing member.

The aggregate consideration paid at the Closing to Tempo and Tempo Blocker securityholders was approximately $1.016 billion in cash, (ii) a number of shares of Alight Class A Common Stock and Class A Units of Alight Holdings (together with an equal number of shares of Alight Class V common stock) in the aggregate equal to 226,663,750, (iii) a number of shares of Alight Class B-1 common stock and Class B-1 Units of Alight Holdings (“Class B-1 Units”) in the aggregate equal to 7,500,000 and (iv) a number of shares of Alight Class B-2 common stock and Class B-2 Units of Alight Holdings (“Class B-2 Units”) in the aggregate equal to 7,500,000, which consideration was allocated among such holders pursuant to the allocation schedule provided by Tempo pursuant to the Business Combination Agreement.

The description of the Business Combination Agreement, the Alight Business Combination and related transactions in this report does not ~~commenced any operations.~~ purport to be complete and is subject, and qualified in its entirety by reference, to the full text of the Business Combination Agreement and other exhibits which are attached as exhibits to the Form 8-K filed by the Company on July 12, 2021.

Business Prior to the Business Combination

All activity for the period from March 26, 2020 (inception) through ~~September~~June 30, ~~2020~~2021 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, ~~and~~ identifying a target company for aan initial business combination and consummating the Alight Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on May 26, 2020. On May 29, 2020, the Company consummated the Initial Public Offering of 103,500,000 units (the “Units” and, with respect to the Class A common stock included in the Units sold, the “Public Shares” and with respect to the warrants included in the Units sold, the “Public Warrants”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 13,500,000 Units, at $10.00 per Unit, generating gross proceeds of $1,035,000,000, which is described in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 15,133,333 warrants (the “Private Placement Warrants” and, collectively with the Public Warrants, the “Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Trasimene Capital Management FT, LP, an affiliate of Trasimene Capital Management, LLC, and Bilcar FT, LP, an affiliate of Bilcar Limited Partnership (collectively the “Sponsors”), generating gross proceeds of $22,700,000, which is described in Note 4.

Transaction costs amounted to $57,949,954, consisting of $20,700,000 of underwriting fees, $36,225,000 of deferred underwriting fees and $1,024,954 of other offering costs. In addition, as of September 30, 2020, cash of $579,370 was held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes.

Following the closing of the Initial Public Offering on May 29, 2020, an amount of $1,035,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, ~~(the “Investment Company Act”),~~ with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below.

Table of Contents

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions and taxes payable on the interest earned in the Trust Account) at the time the Company signs a definitive agreement in connection with a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.ALIGHT GROUP, INC.

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.
)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
~~SEPTEMBER~~

JUNE 30, ~~2020~~
2021

(Unaudited)

The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Second Amended and Restated Certificate of Incorporation (the “Second Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined in Note 5), and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote to approve a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the Initial Public transaction or do not vote at all.

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Second Amended and Restated Articles of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.

The Sponsors have agreed (a) to waive their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Second Amended and Restated Articles of Incorporation (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to consummate a Business Combination.

The Company will have until May 29, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The Sponsors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsors acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

In order to protect the amounts held in the Trust Account, the Sponsors have agreed that they will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent public accountants), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

~~Liquidity and Capital Resources~~

~~As of September 30, 2020, the Company had $579,370 in its operating bank account, and working capital of approximately $635,000.~~

The Company's liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of $250,000 from the Sponsor pursuant to a Note (defined below, see Note 5), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note as of May 29, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's officers and directors may, but are not obligated to, provide the Company Working Capital Loans (defined below, see Note 5). As of September 30, 2020, there were no amounts outstanding under the Working Capital Loans.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company's officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

~~FOLEY TRASIMENE ACQUISITION CORP.~~
~~NOTES TO CONDENSED FINANCIAL STATEMENTS~~
~~SEPTEMBER 30, 2020~~
~~(Unaudited)~~

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s ~~final prospectus for its Initial Public Offering~~Annual Report on 10-K/A, as amended, as filed with the SEC on ~~May 28, 2020, as well as the audited balance sheet included in the Company’s Current Report on Form 8-K, as filed with the SEC on June 4, 2020.~~April 29, 2021. The interim results for the three and six months ended ~~September~~June 30, ~~2020 and for the period from March 26, 2020 (inception) through September 30, 2020~~2021 are not necessarily indicative of the results to be expected for the year ending December 31, ~~2020~~2021 or for any future interim periods.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial ~~statements~~statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

issuance of Class A common stock as a matter of Delaware law. In no event will the Class B common stock convert into Class A common stock at a rate of less than ~~one~~1 to ~~one.~~1.

~~Warrants.~~NOTE 8. WARRANTS

As of June 30, 2021 and December 31, 2020, there were 34,500,000 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

~~FOLEY TRASIMENE ACQUISITION CORP.~~
~~NOTES TO CONDENSED FINANCIAL STATEMENTS~~
~~SEPTEMBER 30, 2020~~
~~(Unaudited)~~

The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless the Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the issuance of the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied the excess of the “fair market value” less the exercise price of the warrants by (y) the fair market value and (B) 0.361. The “fair market value” shall mean the volume weighted average price of the Class A common stock for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.

Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds ~~$18.00~~$18.00 — Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

~~in whole and not in part;~~

●

in whole and not in part;

●

at a price of $0.01 per Public Warrant;

●

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

●

if, and only if, the last reported sale price of the Class A common stock for any 20 trading days within a 30 trading day period ending three business days before sending the notice of redemption to warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like).

Table of ~~$0.01 per Public Warrant;~~

Contents

ALIGHT GROUP, INC.

~~upon not less than~~

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, ~~days’ prior written notice of redemption to each warrant holder; and~~2021

(Unaudited)

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, ~~we will~~the Company has agreed not to redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period.

Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds ~~$10.00~~$10.00 — Once the warrants become exercisable, the Company may redeem the outstanding warrants:

~~in whole and not in part;~~

●

in whole and not in part;

●

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined, based on the redemption date and the “fair market value” of the Class A common stock;

●

if, and only if, the Reference Value (as defined in the above under “Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like); and

●

if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) the Private Placement Warrants must also be concurrently called for redemption on the same terms (except as described below with respect to a holder’s ability to cashless exercise its warrants) as the outstanding public warrants, as described above.

if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) the private placement warrants must also be concurrently called for redemption on the same terms (except as described below with respect to a holder’s ability to cashless exercise its warrants) as the outstanding public warrants, as described above.

~~FOLEY TRASIMENE ACQUISITION CORP.~~
~~NOTES TO CONDENSED FINANCIAL STATEMENTS~~
~~SEPTEMBER 30, 2020~~
~~(Unaudited)~~

The exercise price and number of shares of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. ~~If the Company is unable to complete a Business Combination within the Combination Period~~

As of June 30, 2021 and ~~the Company liquidates the funds held in the Trust Account, holders of Public~~December 31, 2020, there were 15,133,333 Private Placement Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

In addition, if (x) the Company issues additional Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsors or their affiliates, without taking into account any Founder Shares held by the Sponsors or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described above adjacent to “Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00” and “Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x) the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the Class A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

NOTE 8.9. FAIR VALUE MEASUREMENTS

The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts.

At September 30, 2020, assets held in the Trust Account were comprised of $193 in cash and $1,035,519,088 in U.S. Treasury securities. During the three months ended September 30, 2020 and for the period from March 26, 2020 (inception) through September 30, 2020, the Company did not withdraw any interest income from the Trust Account.

~~The gross holding gains and fair value of held-to-maturity securities at September 30, 2020 are as follows:~~

Held-To-Maturity Amortized
Cost Gross
Holding
Gain Fair Value
September 30, 2020 U.S. Treasury Securities (Mature on 11/27/2020) $ 1,035,519,088 $ 93,546 $ 1,035,612,634

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

~~FOLEY TRASIMENE ACQUISITION CORP.~~
~~NOTES TO CONDENSED FINANCIAL STATEMENTS~~
~~SEPTEMBER 30, 2020~~
~~(Unaudited)~~

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

	~~Level 1:~~	Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

	~~Level 2:~~	Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

	Level 3:	Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were 0 transfers into or out of Level 3 fair value measurements in the six months ended June 30, 2021.

Investments Held in Trust

As of June 30, 2021 and December 31, 2020, assets held in the Trust Account were comprised of $1,036,010,297 and $383 in cash and 0 and $1,035,848,884 in U.S. Treasury securities, respectively. During the six months ended June 30, 2021 and 2020 and the year ended December 31, 2020, the Company did not withdraw any interest income from the Trust Account.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. As of June 30, 2021, all investments held in trust were held in cash and are therefore excluded from the table below. The gross holding gains and fair value of held-to-maturity securities at December 31, 2020 are as follows:


					Gross
			Amortized		Holding
	Held-To-Maturity	Level	Cost		Gain		Fair Value

December 31,2020	U.S. Treasury Securities (Matured on 2/25/2021)	1	$	1,035,848,884	$	22,518	$	1,035,871,402

Warrant and Forward Purchase Liabilities

The Warrants and FPAs are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in the fair value of the warrant and FPA liabilities are recorded in the statement of operations each period.

The following table presents the fair value hierarchy for liabilities measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020:


As of June 30, 2021
	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	71,760,000	$	—	$	—	$	71,760,000
Private Placement Warrants		—		—		33,747,333		33,747,333
Total warrant liabilities	$	71,760,000	$	—	$	33,747,333	$	105,507,333
Forward Purchase liability	$	—	$	—	$	15,000,822	$	15,000,822

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)


As of December 31, 2020
	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	87,285,000	$	—	$	—	$	87,285,000
Private Placement Warrants		—		—		40,103,332		40,103,332
Total warrant liabilities	$	87,285,000	$	—	$	40,103,332	$	127,388,332
Forward Purchase liability	$	—	$	—	$	54,277,110	$	54,277,110

The Public Warrants were valued using the instrument’s publicly listed trading price (NYSE: WPF.WS) as of June 30, 2021 and December 31, 2020.

The Private Placement Warrants were valued using a Modified Black Scholes Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes Model uses a Black Scholes Option Pricing Model that is modified to reduce the value of the Private Placement Warrants for a discount for the lack of marketability of the instrument as well as for the probability of consummation of the Business Combination. The model utilizes key inputs including the probability of consummation of a Business Combination, a discount for the lack of marketability, implied volatility of the underlying securities indirectly derived based on comparable public company trading data, risk free interest rates based on US treasury rates, the expected time to consummation of a Business Combination based on the probability of consummation and expiration date of the warrants based on the contractual warrant terms. The primary unobservable inputs utilized in determining the fair value of the Private Placement Warrants is the discount for lack of marketability and the probability of consummation of the Business Combination. The discount for lack of marketability was determined using the Finnerty Model at 6.0%. The probability assigned to the consummation of the Business Combination was 100% which was determined based on a hybrid approach of both observed success rates of business combinations for special purpose acquisition companies and the Sponsors’ track record for consummating similar transactions.

The following table presents a summary of the changes in the fair value of the Private Placement Warrants, a Level 3 liability, measured on a recurring basis.


	Private Placement
	Warrant Liability
Fair value, December 31, 2020	$	40,103,332
Gain on change in fair value (1)		(14,830,666)
Fair value, March 31, 2021		25,272,666
Loss on change in fair value (1)		8,474,667
Fair value, June 30, 2021	$	33,747,333

Fair value, May 29, 2020	$	21,489,333
Loss on change in fair value (1)		3,480,666
Fair value, June 30, 2020	$	24,969,999

(1) Represents the non-cash (gain) loss on the change in valuation of the Private Placement Warrants and is included in Change in fair value of warrant liability on the unaudited condensed statement of operations.

The liability for the FPAs was valued using an adjusted net assets method, which is considered to be a Level 3 fair value measurement. Under the adjusted net assets method utilized, the aggregate commitment of $300,000,000 pursuant to the FPAs is discounted to present value and compared to the fair value of the common stock and warrants to be issued pursuant to the FPAs. The fair value of the common stock and warrants to be issued under the FPAs are based on the public trading price of the Units issued in the Company’s IPO. The excess (liability) or deficit (asset) of the fair value of the common stock and warrants to be issued compared to the $300 million fixed commitment is then reduced to account for the probability of consummation of the Business Combination. The method uses key inputs including probability of consummation of a business combination, the contractual fixed purchase commitment of $300 million, the publicly listed trading prices of the underlying securities to be purchased pursuant to the FPAs, risk free interest rates based on US treasury rates and the expected time to consummation of a Business Combination based on the probability of consummation. The primary

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

unobservable input utilized in determining the fair value of the FPAs is the probability of consummation of the Business Combination. As of December 31, 2020, the probability assigned to the consummation of the Business Combination was 100% which was determined based on a hybrid approach of both observed success rates of business combinations for special purpose acquisition companies and the Sponsors’ track record for consummating similar transactions.

The following table presents a summary of the changes in the fair value of the FPA liability, a Level 3 liability, measured on a recurring basis.


	Forward Purchase
	Liability
Fair value, December 31, 2020	$	54,277,110
Gain on change in fair value (1)		(34,305,798)
Fair value, March 31, 2021		19,971,312
Gain on change in fair value (1)		(4,970,490)
Fair value, June 30, 2021	$	15,000,822

Fair value, May 29, 2020	$	—
Loss on change in fair value (1)		18,909,921
Fair value June 30, 2020	$	18,909,921

(1) Represents the non-cash (gain) loss on the change in valuation of the liability for the FPAs and is included in Change in fair value of forward purchase liability on the unaudited condensed consolidated statement of operations.

NOTE 9.10. SUBSEQUENT EVENTS

On July 2, 2021, the Company consummated the Alight Business Combination. See further discussion in Note 1. In conjunction with the consummation of the Alight Business Combination, the Company disbursed all investments held in the Trust Account which funded, in part, the Alight Business Combination and paid the Deferred Underwriting Fee.

Immediately prior to the Alight Business Combination, pursuant to the FPAs, Cannae purchased from FTAC, and FTAC issued to Cannae, 15,000,000 shares of FTAC Class A Common Stock and 5,000,000 FTAC Warrants for an aggregate purchase price of $150,000,000 and THL purchased from FTAC, and FTAC issued to THL, 15,000,000 shares of FTAC Class A Common Stock and 5,000,000 FTAC Warrants for an aggregate purchase price of $150,000,000. Such proceeds formed a portion of the consideration used for the completion of the Alight Business Combination.

Registration Rights Agreement

On the Closing Date, in connection with the closing of the Alight Business Combination, Alight entered into the Registration Rights Agreement (the “Registration Rights Agreement”), dated as of July 2, 2021, with the Sponsor Investors, the Blackstone Investors and the other Existing Investors (collectively, the “RRA Parties”).

Pursuant to the Registration Rights Agreement, Alight is required, as soon as practicable, but in any event within 30 days after the Closing Date, to file a registration statement to permit the public resale of all “Registrable Securities” (as defined in the Registration Rights Agreement) held by the RRA Parties from time to time as permitted by Rule 415 under the Securities Act. In addition, upon the demand of any such RRA Party, Alight will be required to facilitate a non-shelf registered offering of shares of Class A common stock requested by such RRA Party to be included in such offering. Any demanded non-shelf registered offering may, at Alight’s option, include shares of Class A common stock to be sold by Alight for its own account and will also include registrable shares to be sold by holders that exercise their related piggyback rights in accordance with the Registration Rights Agreement. Within 90 days after receipt of a demand for such registration, Alight will be required to use its reasonable best efforts to file a registration statement relating to such demand. In certain circumstances, the RRA Parties will be entitled to piggyback registration rights in connection with the demand of a non-shelf registered offering.

Table of Contents

ALIGHT GROUP, INC.

(F/K/A FOLEY TRASIMENE ACQUISITION CORP.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021

(Unaudited)

In addition, the Registration Rights Agreement will entitle the RRA Parties to demand and be included in a shelf registration when Alight is eligible to sell its shares of Class A common stock in a secondary offering on a delayed or continuous basis in accordance with Rule 415 of the Securities Act.

The Registration Rights Agreement also provides that Alight will pay certain expenses relating to such registrations and indemnify the registration rights holders against (or make contributions in respect of) certain liabilities which may arise under the Securities Act.

Warrant Assumption Agreement

In connection with the completion of the Alight Business Combination, FTAC entered into a Warrant Assumption Agreement, dated as of July 2, 2021, by and among FTAC, Alight and Continental Stock Transfer & Trust Company, ~~evaluated subsequent events~~a New York corporation (“Continental”, and ~~transactions~~such agreement, the “Warrant Assumption Agreement”). Pursuant to the Warrant Assumption Agreement, at the effective time of the FTAC Merger (the “FTAC Effective Time”), FTAC assigned to Alight, and Alight assumed, all of FTAC’s rights and obligations under the Warrant Agreement, dated as of May 29, 2020, by and between FTAC and Continental, as warrant agent (the “Warrant Agreement”), including the obligation to issue shares of Alight Class A Common Stock upon the exercise of the Warrants.

Tax Receivable Agreement

On the Closing Date, in connection with the completion of the Alight Business Combination, Alight entered into a tax receivable agreement (the “Tax Receivable Agreement”), with FTAC, Tempo and certain of the former direct and indirect equityholders of Tempo, including the former equityholders of the Tempo Blockers (such equityholders, together, the “TRA Parties”) and Blackstone Capital Partners VII NQ L.P., as the representative of the TRA Parties (the “TRA Party Representative”).

The Tax Receivable Agreement provides for the payment by Alight to such TRA Parties of 85% of the benefits, if any, that ~~occurred~~Alight is deemed to realize (calculated using certain assumptions) as a result of (i) Alight’s direct and indirect allocable share of existing tax basis acquired in the Alight Business Combination, (ii) increases in Alight’s allocable share of existing tax basis and tax basis adjustments that will increase the tax basis of the tangible and intangible assets of Alight Holdings as a result of the Business Combination and as a result of sales or exchanges of Alight Holdings Units for shares of Alight Class A common stock after the ~~balance sheet date up~~Business Combination and (iii) Alight’s utilization of certain tax attributes of the Tempo Blockers (including the Tempo Blockers allocable share of existing tax basis), and of certain other tax benefits related to entering into the Tax Receivable Agreement, including tax benefits attributable to payments under the Tax Receivable Agreement. These increases in existing tax basis and tax basis adjustments generated over time may increase (for tax purposes) depreciation and amortization deductions and, therefore, may reduce the amount of tax that Alight would otherwise be required to pay in the future, although the IRS may challenge all or part of the validity of that tax basis, and a court could sustain such a challenge. Actual tax benefits realized by Alight may differ from tax benefits calculated under the Tax Receivable Agreement as a result of the use of certain assumptions in the Tax Receivable Agreement, including the use of an assumed weighted-average state and local income tax rate to calculate tax benefits. The payment obligation under the Tax Receivable Agreement is an obligation of Alight and not of Alight Holdings. While the amount of existing tax basis, the anticipated tax basis adjustments and the actual amount and utilization of tax attributes, as well as the amount and timing of any payments under the Tax Receivable Agreement, will vary depending upon a number of factors, including the timing of exchanges of Alight Holdings Units for shares of Alight Class A common stock, the applicable tax rate, the price of shares of Alight Class A common stock at the time of exchanges, the extent to which such exchanges are taxable and the amount and timing of Alight’s income, Alight expects that as a result of the size of the transfers and increases in the tax basis of the tangible and intangible assets of Alight Holdings and Alight’s possible utilization of tax attributes, including existing tax basis acquired at the time of the Business Combination, the payments that Alight may make under the Tax Receivable Agreement may be substantial. The payments under the Tax Receivable Agreement are not conditioned on the exchanging holders of Alight Holdings Units or other TRA Parties continuing to hold ownership interests in Alight Holdings or Alight. To the extent payments are due to the TRA Parties under the Tax Receivable Agreement, the payments are generally required to be made within 10 business days after the tax benefit schedule (which sets forth Alight’s realized tax benefits covered by the Tax Receivable Agreement for the relevant taxable year) is finalized. Alight is required to deliver such a tax benefit schedule to the TRA Parties’ representative, for its review, within 90 calendar days after the due date ~~that~~(including extensions) of Alight’s federal corporate income tax return for the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.relevant taxable year.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Alight Group, Inc. (f/k/a Foley Trasimene Acquisition Corp.). References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsors” refer to Trasimene Capital Management FT, LP, an affiliate of Trasimene Capital Management, LLC, and Bilcar FT, LP, an affiliate of Bilcar Limited Partnership. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly ~~Report.~~Report and the audited financial statements and Management Discussion and Analysis contained in the Company Form 10-K/A for the period ended December 31, 2020. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s ~~final prospectus for its Initial Public Offering~~Annual Report on Form 10-K/A filed with the U.S. Securities and Exchange Commission (the “SEC”). on April 29, 2020. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We ~~are~~were a blank check company incorporated on March 26, 2020 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses. We have not selected any specific Business Combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any Business Combination target. We intend to effectuate our initial Business Combination using cash from the proceeds of our Initial Public Offering and the private placement of the Private Placement Warrants, the proceeds of the sale of our shares in connection with our initial Business Combination, shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.
~~The registration statement for our Initial Public Offering was declared effective on May 26, 2020. On May 29, 2020, we~~ completed our Initial Public Offering of 103,500,000 Units, which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 13,500,000 units, sold to the public at the price of $10.00 per Unit, generating gross proceeds of $1,035,000,000. Each Unit consists of one share of our Class A common stockon May 29, 2020 and one-third of one redeemable warrant. Each whole Public Warrant entitles the holder to purchase one share of our Class A common stock at an exercise price of $11.50 per share, subject to adjustment. Simultaneously with the closing of our Initial Public Offering, we completed the sale to the Sponsors of an aggregate of 15,133,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, generating gross proceeds of approximately $22,700,000. Each Private Placement Warrant is exercisable for one share of our Class A common stock at a price of $11.50 per share, subject to adjustment. The proceeds from the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account.
Following our Initial Public Offering, the full exercise of the over-allotment option and the sale of the Private Placement Warrants, a total of $1,035,000,000 was placed in the Trust Account. We incurred $57,949,954 in transaction costs, including $20,700,000 of underwriting fees, $36,225,000 of deferred underwriting fees and $1,024,954 of other offering costs.
~~The issuance of additional shares in connection with an initial~~Alight Business Combination ~~including the issuance of forward purchase securities:~~on July 2, 2021.
● may significantly dilute the equity interest of investors, which dilution would increase if the anti-dilution provisions in our Class B common stock resulted in the issuance of our Class A common stock on a greater than one-to-one basis upon conversion of our Class B common stock;
● ~~may subordinate the rights of holders of our Class A common stock if shares of preferred stock are issued with rights senior to those afforded our Class A common stock;~~
● could cause a change in control if a substantial number of shares of our Class A common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

● ~~may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and~~
● ~~may adversely affect prevailing market prices for our Class A common stock and/or warrants.~~

~~Similarly, if~~If we issue debt securities or otherwise incur significant debt, it could result in:
● default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
● acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
● our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;
● our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;
● our inability to pay dividends on our Class A common stock;
● using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions and fund other general corporate purposes;

Table of Contents


	●	limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;


	●	increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and


	●	limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements and execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

We expect to continue to incur significant costs in the pursuit of our initial Business Combination. We cannot assure you that our plans to complete our initial Business Combination will be successful.Recent Developments

~~Results of Operations~~

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for our Initial Public Offering and identifying a target company for our initial Business Combination. We do not expect to generate any operating revenues until after completion of our initial Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses as we conduct due diligence on prospective Business Combination candidates.

For the three months ended September 30, 2020, we had a net income of $155,641, which consists of operating costs of $161,771 and a provision for income taxes of $72,413, offset by interest income on marketable securities held in the Trust Account of $394,825.

For the period from March 26, 2020 (inception) through September 30, 2020, we had a net income of $154,057, which consists of formation and operating costs of $277,175 and a provision for income taxes of $88,049, offset by interest income on marketable securities held in the Trust Account of $519,281.

~~Liquidity and Capital Resources~~

~~Until the consummation of the Initial Public Offering, the Company’s only source of liquidity was an initial purchase of Class B ordinary shares by our Sponsor and loans from our Sponsor.~~

For the period from March 26, 2020 (inception) through September 30, 2020, cash used in operating activities was $440,676. Net income of $154,057 was affected by interest earned on marketable securities held in the Trust Account of $519,281 and changes in operating assets and liabilities, which used $75,452 of cash from operating activities.

As of September 30, 2020, we had cash and marketable securities of $1,035,519,281 held in the Trust Account. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial Business Combination. We may withdraw interest to pay taxes. During the period ended September 30, 2020, we did not withdraw any interest earned on the Trust Account. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2020, we had cash of $579,370 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants identical to the Private Placement Warrants, at a price of $1.50 per warrant at the option of the lender.

We do not currently believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating our initial Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our initial Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our initial Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial Business Combination. If we are unable to complete our initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our initial Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

In March 2020, the World Health Organization classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19 outbreak on our results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19 outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy continue to be impacted for an extended period, our ability to complete our initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the COVID-19 outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit our ability to have meetings with potential investors or affect the ability of a potential target ~~company's~~company’s personnel, vendors and service providers to negotiate and consummate our initial Business Combination in a timely manner.

~~Off-Balance Sheet Financing Arrangements~~On July 2, 2021, we completed the Alight Business Combination. See Note 1 to our condensed consolidated financial statements included in Item 1 of Part I of this Quarterly Report for further discussion.

Results of Operations

We have ~~no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September~~neither engaged in any operations nor generated any revenues through June 30, ~~2020.~~2021. Our only activities from inception to June 30, 2021 have been organizational activities, those necessary to prepare for our Initial Public Offering, identifying a target company and completing our initial Business Combination. We do not ~~participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred~~expect to ~~as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into~~generate any ~~off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.~~

~~Contractual Obligations~~

~~We do not have any long-term debt, capital lease obligations,~~ operating ~~lease obligations or long-term liabilities, other than an agreement to pay an affiliate~~revenues until after completion of our ~~Sponsors~~initial Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a ~~monthly fee up~~result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses as we prepare for closing of our Business Combination.

For the three months ended June 30, 2021, we had net loss of $24,255,480, which consists of consists of non-cash loss of $25,034,667 and gain of $4,970,490 related to ~~$5,000 for office space and administrative support services. We began incurring these fees on May 26, 2020 and will continue to incur these fees monthly until~~changes in the ~~earlier~~fair value of the ~~completion of the Business Combination and our liquidation.~~

~~Pursuant to a registration rights agreement entered into on May 26, 2020, the holders of the Founder Shares, Private Placement~~ Warrants and ~~warrants that may be issued upon conversion~~FPAs, respectively, formation and operating costs of $4,175,988 and interest income on the Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and stockholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

~~The underwriters are entitled to a deferred fee of $0.35 per Unit, or $36,225,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts~~investments held in the Trust Account ~~solely~~of $24,979, offset by a provision for income taxes of $40,294.

For the six months ended June 30, 2021, we had net income of $53,826,180, which consists of consists of non-cash gains of $21,880,999 and $39,276,288 related to changes in the ~~event that~~fair value of the ~~Company completes~~Warrants and FPAs, respectively, formation and operating costs of $7,433,772 and interest income on the investments held in the Trust Account of $161,030, offset by a provision for income taxes of $58,365.

A majority of our formation and operating costs for the three and six months ended June 30, 2021 related to costs associated with completion of the Business Combination.

For the three months ended June 30, 2020, we had a net loss of $31,016,213, which consists of formation and operational costs of $109,445, interest earned on marketable securities held in Trust Account of $124,456, change in fair value of forward purchase liability of $18,909,921, change in fair value of warrant liability of $12,105,667, and provision for income taxes of $15,636.

For the period from March 26, 2020 (inception) through June 30, 2020, we had a net loss of $(31,017,171), which consists of formation and operating costs of $110,404, interest earned on marketable securities held in Trust Account of $124,456, change in fair value of forward purchase liability of $18,909,921, change in fair value of warrant liability of $(12,105,666), and provision for income taxes of $15,636.

Table of Contents

Liquidity and Capital Resources

As of June 30, 2021, we had cash of $14,551 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to continue business due diligence on prospective target businesses, and structure, negotiate and complete our initial Business Combination. In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, ~~subject~~our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. As of June 30,2021 the ~~terms~~Sponsor had advanced $1,138,058 for working capital which was repaid upon closing of the ~~underwriting agreement.~~Alight Business Combination.

WeIn May 2020, the Company entered into forward purchase agreements (the “FPAs”) with each of Cannae Holdings, Inc. and THL FTAC LLC. Pursuant to each agreement, Cannae Holdings, Inc. and THL FTAC LLC have each agreed to purchase shares of ~~our~~the Company’s Class A common stock in an aggregate share amount equal to 15,000,000 shares of the ~~our~~Company’s Class A Common stock (or a total of 30,000,000 shares of the ~~our~~Company’s Class A common stock), plus an aggregate of 5,000,000 redeemable warrants (or a total of 10,000,000 redeemable warrants) to purchase one share of the Company’s Class A common stock at $11.50 per share, for an aggregate purchase price of $150,000,000 (or a total of $300,000,000), or $10.00 for one share of ~~our~~the Company’s Class A common stock and one-third of one warrant, in a private placement to occur concurrently with the closing of a Business Combination. The warrants to be sold as part of the ~~forward purchase agreements~~FPAs will be identical to the warrants underlying the Units sold in the Initial Public Offering. The FPAs closed commensurate with the closing of the Alight Business Combination.

As of June 30, 2021, we had cash and marketable securities of $1,036,010,297 held in the Trust Account. We used all of the funds held in the Trust Account to fund a portion of the Alight Business Combination.

For the six months ended June 30, 2021, cash used in operating activities was $481,920. Net income of $53,826,180 was affected by the non-cash gain on the change in fair value of the Warrants of $21,880,999, non-cash gain on the change in fair value of the FPAs of $39,276,288, interest earned on marketable securities held in the Trust Account of $161,030 and changes in operating assets and liabilities, which provided $7,010,217 of cash from operating activities.

For the period from March 26, 2020 (inception) through June 30, 2020, cash used in operating activities was $334,857. Net loss of $(31,017,171) was affected by the non-cash loss on the change in fair value of the Warrants of $(12,105,666), non-cash loss on the change in fair value of the FPAs of $18,909,921, interest earned on marketable securities held in the Trust Account of $124,456 and changes in operating assets and liabilities, which used $208,817 of cash from operating activities.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements within the meaning of the applicable SEC rules as of June 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

As of June 30, 2021, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $36,225,000 in the aggregate. The deferred fee became payable to the underwriters from the amounts held in the Trust Account in connection with the completion of the Alight Business Combination.

Table of Contents

Critical Accounting ~~Policies~~Estimates

The preparation of unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting ~~policies:~~estimates:

Warrant and Forward Purchase Liabilities

The Company accounts for the Warrants and FPAs as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the Warrants and FPAs and the applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the Warrants and FPAs are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815, including whether the Warrants and FPAs are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance of the Warrants and execution of the FPAs and as of each subsequent quarterly period end date while the Warrants and FPAs are outstanding. For issued or modified instruments such as warrants and forward purchases of equity that meet all of the criteria for equity classification, such instruments are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified instruments that do not meet all the criteria for equity classification, such instruments are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of liability-classified instruments are recognized as a non-cash gain or loss on the statements of operations.

The Company accounts for the Warrants and FPAs in accordance with ASC 815-40 under which the Warrants and FPAs do not meet the criteria for equity classification and must be recorded as liabilities. The liabilities for the Warrants and FPAs are included in Warrant liability and Forward purchase liability, respectively, on the condensed consolidated balance sheets as of June 30, 2021 and December 31, 2020. See Note 8 to our unaudited condensed consolidated financial statements included in Item 1 of Part I of this Quarterly Report for further discussion of the pertinent terms of the Warrants and Note 9 for further discussion of the methodology used to determine the fair value of the warrant and forward purchase liabilities.

Common Stock Subject to Possible Redemption

We account for our common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our unaudited condensed consolidated balance sheet.

Net ~~Loss~~Income (Loss) per Common Share

We apply the two-class method in calculating ~~earnings~~income or loss per share. Net income (loss) per common share, basic and diluted for Class A redeemable common stock is calculated by dividing the interest income earned on the Trust Account for the period, net of applicable taxes, by the weighted average number of shares of Class A redeemable common stock outstanding ~~for~~during the ~~periods.~~period. Net income (loss) per common share, basic and diluted for and Class B non-redeemable common stock is calculated by dividing net income less income attributable to Class A redeemable common stock for the period, by the weighted average number of shares of Class B non-redeemable common stock outstanding ~~for~~during the periods presented.

Table of Contents

Recent Accounting Standards

In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, with early adoption permitted. The Company has not adopted ASU 2020-06 and is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on ~~our unaudited condensed~~the Company’s consolidated financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As of ~~September~~June 30, ~~2020,~~2021, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering, the net proceeds received into the Trust Account, ~~have been~~were invested in U.S. government treasury bills, notes or bonds with a maturity of 185 days or less or in certain money market funds that invest solely in US treasuries. ~~Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.~~

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of ~~September~~June 30, ~~2020.~~2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were ~~effective.~~not effective as of June 30, 2021, due solely to the material weakness in our internal control over financial reporting to the classification of the Company’s Warrants or FPAs as components of equity instead of as derivative liabilities. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Table of Contents

Changes in Internal Control ~~Over~~over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, as the circumstances that led to the Revision of our financial statements described in this Quarterly Report on Form 10-Q had not yet been identified. Management has implemented remediation steps to address the material weakness and to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex securities and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. As of June 30, 2021, this has not been fully remediated.

Table of Contents

PART II - OTHER INFORMATION

~~ITEM 1. LEGAL PROCEEDINGS.~~
~~None.~~
ITEM 1A. RISK FACTORS.

~~Factors that could cause our actual results to differ materially from those in this Quarterly Report are any~~As a result of the ~~risks~~recent closing of the Alight Business Combination on July 2, 2021, the risk factors previously described in our ~~final prospectus~~Annual Report on Form 10-K/A for ~~our Initial Public Offering~~the fiscal year ended December 31, 2020, filed with the SEC on ~~May 28, 2020.~~April 29, 2021 are generally no longer applicable. For risk factors relating to our business following the Alight Business Combination, please refer to the section entitled “Risk Factors” in our definitive proxy statement/final prospectus filed with the SEC on June 4, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus for our Initial Public Offering filed with the SEC on May 28, 2020. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
~~Unregistered Sales of Equity Securities~~
Simultaneously with the consummation of the Initial Public Offering and the full exercise of the over-allotment option, we consummated a private placement of 15,133,333, Private Placement Warrants to our Sponsor at a price of $1.50 per Private Placement Warrant, generating total proceeds of $22,700,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees.

Use of Proceeds

On May 29, 2020, we consummated our Initial Public Offering of 103,500,000 Units, inclusive of the underwriters’ election to fully exercise their overallotment option to purchase an additional 13,500,000 Units. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $1,035,000,000. Credit Suisse Securities (USA) LLC and BofA Securities, Inc. acted as the joint book-running managers. The securities sold in the offering were registered under the Securities Act on registration statement on Form S-1 (No. 333-238135). The SEC declared the registration statement effective on May 26, 2020.

Of the gross proceeds received from the Initial Public Offering, $1,035,000,000 was placed in the Trust Account.

We paid a total of $20,700,000 in underwriting discounts and commissions and $1,024,954 for other offering costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer $36,225,000 in underwriting discounts and commissions.

~~For a description~~

Table of ~~the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.~~Contents

~~ITEM 3. DEFAULTS UPON SENIOR SECURITIES.~~
~~None.~~
~~ITEM 4. MINE SAFETY DISCLOSURES.~~
~~Not applicable.~~
~~ITEM 5. OTHER INFORMATION.~~
~~Amended and Restated Bylaws~~
The information set forth below is included herewith for the purpose of providing the disclosures required under “Item 5.03-Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year” of Form 8-K.
On November 5, 2020, our Board of Directors amended and restated the Company’s Bylaws (the “A&R Bylaws”), which became effective as of the date of approval, to increase the maximum number of directors from 5 to 14. The change in the number of directors was the only change in the A&R Bylaws.
The foregoing summary is qualified in its entirety by reference to, the full text of the A&R Bylaws, which are attached hereto as Exhibit 3.2 to this Quarterly Report on Form 10-Q and incorporated herein by reference.

ITEM 6. EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.
Description of Exhibit
3.1

~~3.1~~
~~Second~~ Amended and Restated Certificate of ~~Incorporation.~~Incorporation of Alight, Inc. (1)
3.2

3.2*
Amended and Restated ~~Bylaws.~~Bylaws of Alight, Inc. (1)
~~4.1~~
31.1*
~~Warrant Agreement, dated May 29, 2020, between the Company and Continental Stock Transfer & Trust Company. (1)~~
~~10.1~~ ~~Investment Management Trust Agreement, dated May 29, 2020, between the Company and Continental Stock Transfer & Trust Company. (1)~~
~~10.2~~ ~~Registration Rights Agreement, dated May 29, 2020, among the Company, the Sponsors and certain other security holders named therein. (1)~~
~~10.3~~ ~~Private Placement Warrants Purchase Agreement, dated May 26, 2020, between the Company and the Sponsors. (1)~~
~~10.4~~ ~~Administrative Services Agreement, dated May 22, 2020, between the Company and Cannae Holdings, Inc. (1)~~
~~10.5~~ ~~Letter Agreement, dated May 29, 2020, between the Company and the Sponsors. (1)~~
~~10.6~~ ~~Letter Agreement, dated May 29, 2020, between the Company and each of its officers and directors. (1)~~
~~10.7~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and William P. Foley, II. (1)~~
~~10.8~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and Douglas K. Ammerman. (1)~~
~~10.9~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and Thomas M. Hagerty. (1)~~
~~10.10~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and Hugh R. Harris. (1)~~
~~10.11~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and Frank R. Martire, Jr. (1)~~
~~10.12~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and Richard N. Massey. (1)~~
~~10.13~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and Richard L. Cox. (1)~~
~~10.14~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and David W. Ducommun. (1)~~
~~10.15~~ ~~An Indemnity Agreement, dated May 29, 2020, between the Company and Michael L. Gravelle. (1)~~
31.1* Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
Inline XBRL Instance Document
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase Document
* ~~Filed herewith.~~
104

Cover Page Interactive Data File. The cover page XBRL tags are embedded within the inline XBRL document.
*
Filed herewith.
**
Furnished herewith.
(1)
Previously filed as an exhibit to our Current Report on Form 8-K filed on ~~June 1, 2020~~July 12, 2021 and incorporated by reference herein.

Table of Contents

SIGNATURES
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

~~FOLEY TRASIMENE ACQUISITION CORP.~~
ALIGHT, INC.
Date: ~~November 6, 2020~~August 16, 2021
/s/ ~~Richard N. Massey~~Stephan Scholl
Name:
~~Richard N. Massey~~
Title:
Chief Executive Officer
(Principal Executive Officer)
Date: ~~November 6, 2020~~August 16, 2021
/s/ ~~Bryan Coy~~Katie Rooney
Name:
~~Bryan Coy~~
Title:
Chief Financial Officer
(Principal Financial and Accounting Officer)

~~Delaware~~		~~85-0545098~~
Delaware		86-1849232
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
~~Units, each consisting of one share of Class A common~~ ~~stock and one-third of one redeemable warrant~~	~~WPF.U~~	~~The New York Stock~~ ~~Exchange~~
Class A common stock, par value $0.0001 per share	~~WPF~~ ALIT	The New York Stock Exchange
~~Redeemable warrants, each whole warrant exercisable~~ ~~for~~ Warrants to purchase one share of Class A common stock ~~at an exercise price~~ ~~of $11.50 per share~~	~~WPF~~ ALIT. WS	The New York Stock Exchange

¨
☐ Large accelerated filer	¨ ☐ Accelerated filer
x ⌧ Non-accelerated filer	¨ ☐ Smaller reporting company
	x ☒ Emerging growth company

ASSETS
Current assets
Cash	$	579,370
Prepaid expenses		284,517
Total Current Assets		863,887

Cash and marketable securities held in Trust Account		1,035,519,281
Total Assets	$	1,036,383,168

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued expenses	$	121,016
Accrued offering costs		20,000
Income taxes payable		88,049
Total Current Liabilities		229,065

Deferred underwriting fee payable		36,225,000
Total Liabilities		36,454,065

Commitments and Contingencies

Class A common stock subject to possible redemption, 99,492,910 shares at $10.00 per share		994,929,100

Stockholders’ Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—
Class A common stock, $0.0001 par value; 400,000,000 shares authorized; 4,007,090 issued and outstanding (excluding 99,492,910 shares subject to possible redemption)		401
Class B common stock, $0.0001 par value; 40,000,000 shares authorized; 25,875,000 shares issued and outstanding		2,588
Additional paid-in capital		4,842,957
Retained earnings		154,057
Total Stockholders’ Equity		5,000,003
Total Liabilities and Stockholders’ Equity	$	1,036,383,168

	Three Months Ended September 30,			For the Period from March 26, 2020 (Inception) Through September 30,
	2020			2020
Formation and general and administrative expenses	$	166,771		$	277,175
Loss from operations		(166,771	)		(277,175	)

Other income:
Interest earned on marketable securities held in Trust Account		394,825			519,281

Income before provision for income taxes		228,054			242,106
Provision for income taxes		(72,413	)		(88,049	)
Net income	$	155,641		$	154,057

Weighted average shares outstanding of Class A redeemable common stock		103,500,000			103,500,000
Basic and diluted income per share, Class A	$	0.00		$	0.00

Weighted average shares outstanding of Class B non-redeemable common stock		25,875,000			25,875,000
Basic and diluted net loss per share, Class B	$	(0.00	)	$	(0.01	)

Cash Flows from Operating Activities:
Net income	$	154,057
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(519,281	)
Changes in operating assets and liabilities:
Prepaid expenses		(284,517	)
Accounts payable and accrued expenses		121,016
Income taxes payable		88,049
Net cash used in operating activities		(440,676	)

Cash Flows from Investing Activities:
Investment of cash into Trust Account		(1,035,000,000	)
Net cash used in investing activities		(1,035,000,000	)

Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor		25,000
Proceeds from sale of Units, net of underwriting discounts paid		1,014,300,000
Proceeds from sale of Private Placement Warrants		22,700,000
Proceeds from promissory note - related party		250,000
Repayment of promissory note - related party		(250,000	)
Payment of offering costs		(1,004,954	)
Net cash provided by financing activities		1,036,620,046

Net Change in Cash		579,370
Cash – Beginning of period		—
Cash – End of period	$	579,370

Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Offering costs included in accrued offering costs	$	20,000
Initial classification of Class A common stock subject to possible redemption	$	994,768,320
Change in value of Class A common stock subject to possible redemption	$	160,780
Deferred underwriting fee payable	$	36,225,000


							For the Period
							From
							March 26,2020
	Three Months				Six Months		(inception)
	Ended				Ended		through
	June 30,				June 30,		June 30,
	2021		2020		2021		2020
Redeemable Class A Common Stock
Numerator: Income allocable to Redeemable Class A Common Stock
Interest Income	$	24,979	$	124,456	$	161,030	$	124,456
Income and Franchise Tax		(24,979)		(66,000)		(161,030)		(66,000)
Net Income	$	—	$	58,456	$	—	$	58,456
Denominator: Weighted Average Redeemable Class A Common Stock
Redeemable Class A Common Stock, Basic and Diluted		103,500,000		103,500,000		103,500,000		103,500,000
Earnings per Share/Basic and Diluted Redeemable Class A Common Stock	$	0.00	$	0.00	$	0.00	$	0.00

Non-Redeemable B Common Stock
Numerator: Net loss minus Redeemable Net Income
Net income (loss)	$	(24,255,480)	$	(31,017,171)	$	53,826,180	$	(31,017,171)
Less: Redeemable Net Income		—		(58,456)		—		(58,456)
Non-Redeemable Net Income	$	(24,255,480)	$	(30,958,715)	$	53,826,180	$	(30,958,715)
Denominator: Weighted Average Non-Redeemable B Common Stock
Non-Redeemable B Common Stock, Basic and Diluted		25,875,000		25,875,000		25,875,000		25,875,000
Earnings (loss) per Share/Basic and Diluted Non-Redeemable B Common Stock	$	(0.94)	$	(1.20)	$	2.08	$	(1.20)

			Held-To-Maturity		Amortized Cost				Gross Holding Gain				Fair Value
September 30, 2020			U.S. Treasury Securities (Mature on 11/27/2020)		$	1,035,519,088			$	93,546			$	1,035,612,634

	●	may significantly dilute the equity interest of investors, which dilution would increase if the anti-dilution provisions in our Class B common stock resulted in the issuance of our Class A common stock on a greater than one-to-one basis upon conversion of our Class B common stock;

	●	~~may subordinate the rights of holders of our Class A common stock if shares of preferred stock are issued with rights senior to those afforded our Class A common stock;~~

	●	could cause a change in control if a substantial number of shares of our Class A common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

	●	~~may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and~~

	●	~~may adversely affect prevailing market prices for our Class A common stock and/or warrants.~~


	●	acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;


	●	our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;


	●	our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;


	●	our inability to pay dividends on our Class A common stock;


	●	using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions and fund other general corporate purposes;


No.				Description of Exhibit
	3.1		~~3.1~~		~~Second~~ Amended and Restated Certificate of ~~Incorporation.~~Incorporation of Alight, Inc. (1)
	3.2		3.2*		Amended and Restated ~~Bylaws.~~Bylaws of Alight, Inc. (1)
~~4.1~~ 31.1*		~~Warrant Agreement, dated May 29, 2020, between the Company and Continental Stock Transfer & Trust Company. (1)~~
~~10.1~~		~~Investment Management Trust Agreement, dated May 29, 2020, between the Company and Continental Stock Transfer & Trust Company. (1)~~
~~10.2~~		~~Registration Rights Agreement, dated May 29, 2020, among the Company, the Sponsors and certain other security holders named therein. (1)~~
~~10.3~~		~~Private Placement Warrants Purchase Agreement, dated May 26, 2020, between the Company and the Sponsors. (1)~~
~~10.4~~		~~Administrative Services Agreement, dated May 22, 2020, between the Company and Cannae Holdings, Inc. (1)~~
~~10.5~~		~~Letter Agreement, dated May 29, 2020, between the Company and the Sponsors. (1)~~
~~10.6~~		~~Letter Agreement, dated May 29, 2020, between the Company and each of its officers and directors. (1)~~
~~10.7~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and William P. Foley, II. (1)~~
~~10.8~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and Douglas K. Ammerman. (1)~~
~~10.9~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and Thomas M. Hagerty. (1)~~
~~10.10~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and Hugh R. Harris. (1)~~
~~10.11~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and Frank R. Martire, Jr. (1)~~
~~10.12~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and Richard N. Massey. (1)~~
~~10.13~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and Richard L. Cox. (1)~~
~~10.14~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and David W. Ducommun. (1)~~
~~10.15~~		~~An Indemnity Agreement, dated May 29, 2020, between the Company and Michael L. Gravelle. (1)~~
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

*	~~Filed herewith.~~
104		Cover Page Interactive Data File. The cover page XBRL tags are embedded within the inline XBRL document.

	~~FOLEY TRASIMENE ACQUISITION CORP.~~ ALIGHT, INC.

Date: ~~November 6, 2020~~August 16, 2021		/s/ ~~Richard N. Massey~~Stephan Scholl
	Name:	~~Richard N. Massey~~
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Date: ~~November 6, 2020~~August 16, 2021		/s/ ~~Bryan Coy~~Katie Rooney
	Name:	~~Bryan Coy~~
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)